Local radiological staging of rectal cancer

Clinical Radiology

Volumn 59, Issue 3, 2004, Pages 213-214

  Brown, G ^a  

^a INSTITUTE OF CANCER RESEARCH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

CANCER LOCALIZATION; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; COMPUTER ASSISTED EMISSION TOMOGRAPHY; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC VALUE; ECHOGRAPHY; HUMAN; NOTE; NUCLEAR MAGNETIC RESONANCE IMAGING; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; RADIODIAGNOSIS; RECTUM CANCER; SUPERFICIAL CANCER;

EID: 1442356462     PISSN: 00099260     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.crad.2003.10.001     Document Type: Note

References (16)

1. Goh V, Halligan S, Bartram CI. Local radiological staging of rectal cancer. Clin Radiol 2004;59:215-26.
2. Akasu T, Kondo H, Moriya Y, et al. Endorectal ultrasonography and treatment of early stage rectal cancer. World J Surg 2000;24:1061068.
3. Heald RJ, Moran BJ, Ryall RD, Sexton R, MacFarlane JK. Rectal cancer: the Basingstoke experience of total mesorectal excision, 1978-1997. Arch Surg 1998;133:894-9.
4. Adam IJ, Mohamdee MC, Martin IG, et al. Role of circumferential margin involvement in the local recurrence of rectal cancer. Lancet 1994;344:707-11.
5. Hall NR, Finan PJ, al-Jaberi T, et al. Circumferential margin involvement after mesorectal excision of rectal, cancer with curative intent. Predictor of survival but not local recurrence? Dis Colon Rectum 1998;41:979-83.
6. Marijnen CA, Nagtegaal ID, Kapiteijn E, et al. Radiotherapy does not compensate for positive resection margins in rectal cancer patients: report of a multicenter randomized trial. Int J Radiat Oncol Biol Phys 2003;55:1311-20.
7. Brown G, Richards CJ, Newcombe RG, et al. Rectal, carcinoma: thin-section MR imaging for staging in 28 patients. Radiology 1999;211:215-22.
8. Brown G, Radcliffe AG, Newcombe RG, Dallimore NS, Bourne MW, Williams GT. Preoperative assessment of prognostic factors in rectal cancer using high resolution magnetic resonance imaging. Br J Surg 2003;90:355-64.
9. Bouzourene H, Bosman FT, Seelentag W, Matter M, Coucke P. Importance of tumor regression assessment in predicting the outcome in patients with locally advanced rectal carcinoma who are treated with preoperative radiotherapy. Cancer 2002;94:1121-30.
10. Sauer R. Adjuvant and neoadjuvant radiotherapy and concurrent radiochemotherapy for rectal cancer. Pathol Oncol Res 2002;8:7-17.
11. Kapiteijn E, Marijnen CA, Nagtegaal ID, et al. Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer. N Engl J Med 2001;345:638-46.
12. Brown G, Richards CJ, Bourne MW, et al. Morphological predictors of lymph node status in rectal cancer using high spatial resolution magnetic resonance imaging with histopathological comparison. Radiology 2003;227:371-7.
13. Glimelius B, Jakobsen A, Graf W, et al. Bolus injection (2-4 min) versus short-term (10-20 min) infusion of 5-fluorouracil in patients with advanced colorectal cancer: a prospective randomised trial. Nordic Gastrointestinal Tumour Adjuvant Therapy Group. Eur J Cancer 1998;34:674-8.
14. Moertel CG, Fleming TR, Macdonald JS, et al. Levamisole and fluorouracil for adjuvant therapy of resected colon carcinoma. N Engl J Med 1990;322:352-8.
15. Chau I, Cunningham D, Brown G, et al. Twelve weeks of neoadjuvant capecitabine and oxaliplatin followed by synchronous chemoradiation and total mesorectal excision in magnetic resonance imaging defined poor risk locally advanced rectal cancer resulted in promising tumour regression and rapid symptomatic relief. Proc Am Soc Clin Oncol 2003;22:252.
16. Mercury Study Group. Magnetic Resonance Imaging and Rectal Cancer European Equivalence Study (Mercury). UK: NCRI; 2002.